Can we afford to sequence every newborn baby's genome?

Human Mutation

Volumn 36, Issue 3, 2015, Pages 283-286

  Beckmann, Jacques S ^a  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

Author keywords

NBS; Newborn screening; WES; WGS; Whole exome sequencing; Whole genome sequencing

Indexed keywords

CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DNA SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC LOAD; GENOME ANALYSIS; HEALTH CARE SYSTEM; HUMAN; NEWBORN SCREENING; NOTE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ECONOMICS; HUMAN GENOME; NEWBORN; PROCEDURES;

GENOME, HUMAN; HUMANS; INFANT, NEWBORN; SEQUENCE ANALYSIS, DNA;

EID: 84924626624     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22748     Document Type: Note

References (45)

1. Beckmann JS, Estivill X, Antonarakis SE. 2007. Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 8:639-646.
2. Berg JS, Khoury MJ, Evans JP. 2011. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time. Genet Med 13:499-504.
3. Biesecker LG. 2012. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project. Genet Med 14:393-398.
4. Biesecker LG, Green RC. 2014. Diagnostic clinical genome and exome sequencing. N Engl J Med 370:2418-2425.
5. Botkin JR, Lewis MH, Watson MS, Swoboda KJ, Anderson R, Berry SA, Bonhomme N, Brosco JP, Comeau AM, Goldenberg A, Goldman E, Therrell B, et al. 2014. Parental permission for pilot newborn screening research: guidelines from the NBSTRN. Pediatrics 133:e410-e417.
6. Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, Cook-Deegan R, Fishman J, Hogarth S, Miller FA, Ravitsky V, Biesecker B, Borry P, et al. 2013. Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol 11:e1001699.
7. Centers For Disease Control Prevention. 2011. Ten great public health achievements-United States, 2001-2010. Morbidity and mortality weekly report 60:619.
8. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, Cheng Y, Clark MJ, et al. 2012. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148:1293-1307.
9. Davies K. 2010. The $1000000 genome interpretation. Aust Life Sci 8:50.
10. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, et al. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367:1921-1929.
11. Dewey FE, Grove ME, Pan C, Goldstein BA, Bernstein JA, Chaib H, Merker JD, Goldfeder RL, Enns GM, David SP, Pakdaman N, Ormond KE, et al. 2014. Clinical interpretation and implications of whole-genome sequencing. JAMA 311:1035-1045.
12. Dixon-Salazar TJ, Silhavy JL, Udpa N, Schroth J, Bielas S, Schaffer AE, Olvera J, Bafna V, Zaki MS, Abdel-Salam GH, Mansour LA, Selim L, et al. 2012. Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 4:138ra78.
13. Dondorp WJ, de Wert GM. 2013. The 'thousand-dollar genome': an ethical exploration. Eur J Hum Genet 21:S6-S26.
14. Feero WG. 2014. Clinical application of whole-genome sequencing: proceed with care. JAMA 311:1017-1019.
15. Feero WG, Wicklund C, Veenstra DL. 2013. The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health. JAMA 309:1235-1236.
16. Francke U. 2013. How will genomic information become integrated into the health care system? Mol Genet Genomic Med 1:67-70.
17. Frebourg T. 2014. The challenge for the next generation of medical geneticists. Hum Mutat 35:909-911.
18. Friend SH, Schadt EE. 2014. Translational genomics. Clues from the resilient. Science 344:970-972.
19. Goldenberg AJ, Dodson DS, Davis MM, Tarini BA. 2014. Parents' interest in whole-genome sequencing of newborns. Genet Med 16:78-84.
20. Goldenberg AJ, Sharp RR. 2012. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 307:461-462.
21. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, et al. 2013. ACMGrecommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565-574.
22. Jacob HJ, Abrams K, Bick DP, Brodie K, Dimmock DP, Farrell M, Geurts J, Harris J, Helbling D, Joers BJ, Kliegman R, Kowalski G, et al. 2013. iGenomics in clinical practice: lessons from the front lines. Sci Transl Med 5:194cm5.
23. Jamuar SS, Lam AT, Kircher M, D'Gama AM, Wang J, Barry BJ, Zhang X, Hill RS, Partlow JN, Rozzo A, Servattalab S, Mehta BK, et al. 2014. Somatic mutations in cerebral cortical malformations. N Engl J Med 371:733-743.
24. Johansen Taber KA, Dickinson BD, Wilson M. 2014. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Intern Med 174:275-280.
25. Joly Y, Saulnier KM, Osien G, Knoppers BM. 2014. The ethical framing of personalized medicine. Curr Opin Allergy Clin Immunol 14:404-408.
26. Kemper AR, Green NS, Calonge N, Lam WKK, Comeau AM, Goldenberg AJ, Ojodu J, Prosser LA, Tanksley S, Bocchini JA Jr. 2014. Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children. Genet Med 16:183-187.
27. Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER. 2013. The next-generation sequencing revolution and its impact on genomics. Cell 155:27-38.
28. Landau YE, Lichter-Konecki U, Levy HL. 2014. Genomics in newborn screening. J Pediatr 164:14-19.
29. Manolio TA, Chisholm RL, Ozenberger B, Roden DM, Williams MS, Wilson R, Bick D, Bottinger EP, Brilliant MH, Eng C, Frazer KA, Korf B, et al. 2013. Implementing genomic medicine in the clinic: the future is here. Genet Med 15:258-267.
30. Mardis ER. 2010. The $1000 genome, the $100000 analysis? Genome Med 2:84.
31. Nelen M, Veltman JA. 2012. Genome and exome sequencing in the clinic: unbiased genomic approaches with a high diagnostic yield. Pharmacogenomics 13:511-514.
32. Ormond KE, Wheeler MT, Hudgins L, Klein TE, Butte AJ, Altman RB, Ashley EA, Greely HT. 2010. Challenges in the clinical application of whole-genome sequencing. Lancet 375:1749-1751.
33. Roberts NJ, Vogelstein JT, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. 2012. The predictive capacity of personal genome sequencing. Sci Transl Med 4:133ra58.
34. Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphray S, Saffrey P, et al. 2012. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 4:154ra135.
35. Sboner A, Mu XJ, Greenbaum D, Auerbach RK, Gerstein MB. 2011. The real cost of sequencing: higher than you think! Genome Biol 12:125.
36. Solomon BD. 2014. Incidentalomas in genomics and radiology. N Engl J Med 370:988-990.
37. Solomon BD, Pineda-Alvarez DE, Bear KA, Mullikin JC, Evans JP, Program NCS. 2012. Applying genomic analysis to newborn screening. Mol Syndromol 3:59-67.
38. Tabor HK, Auer PL, Jamal SM, Chong JX, Yu JH, Gordon AS, Graubert TA, O'Donnell CJ, Rich SS, Nickerson DA, Project NES, Bamshad MJ. 2014. Pathogenic variants for Mendelian and complex traits in exomes of 6517 European and African Americans: implications for the return of incidental results. Am J Hum Genet 95:183-193.
39. Tarini BA, Goldenberg AJ. 2012. Ethical issues with newborn screening in the genomics era. Annu Rev Genomics Hum Genet 13:381-393.
40. Teutsch SM, Fielding JE, Khoury MJ, Evans JP. 2014. Utility before business. Genet Med 16:869-870.
41. Vassy JL, Lautenbach DM, McLaughlin HM, Kong SW, Christensen KD, Krier J, Kohane IS, Feuerman LZ, Blumenthal-Barby J, Roberts JS, Lehmann LS, Ho CY, et al. 2014. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials 15:85.
42. Vayena E, Prainsack B. 2013. Regulating genomics: time for a broader vision. Sci Transl Med 5:198ed12.
43. Wade CH, Tarini BA, Wilfond BS. 2013. Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice. Annu Rev Genomics Hum Genet 14:535-555.
44. Wetterstrand K. 2013. DNAsequencing costs: data from the NHGRIgenome sequencing program (GSP). 2013. Retrieved from www.genome.gov/sequencingcosts.
45. Yu JH, Jamal SM, Tabor HK, Bamshad MJ. 2013. Self-guided management of exome and whole-genome sequencing results: changing the results return model. Genet Med 15:684-690.